| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/01/2000 | EP0981544A2 Anti-bacterial methods and materials |
| 03/01/2000 | EP0981541A1 Psca: prostate stem cell antigen |
| 03/01/2000 | EP0981537A1 An infectious clone for human parainfluenza virus type 3 |
| 03/01/2000 | EP0981535A1 Methods for production and purification of nucleic acid molecules |
| 03/01/2000 | EP0981361A1 Method of treating sepsis |
| 03/01/2000 | EP0981331A1 The use of temperature to control the size of cationic liposome/plasmid dna complexes |
| 03/01/2000 | EP0804230B1 Vaccine against mycobacterial infections |
| 03/01/2000 | EP0769020B1 NEW hIL-4 MUTANT PROTEINS USED AS ANTAGONISTS OR PARTIAL AGONISTS OF HUMAN INTERLEUKIN 4 |
| 03/01/2000 | EP0702564B1 Novel attenuated pseudomonas aeruginosa strains |
| 03/01/2000 | EP0666760B1 VACCINE COMPRISING PART OF CONSTANT REGION OF IgE FOR TREATMENT OF IgE-MEDIATED ALLERGIC REACTIONS |
| 03/01/2000 | EP0618926B1 New peptide derivatives |
| 03/01/2000 | CN1246158A Method of PCR testing of pooled blood samples |
| 03/01/2000 | CN1246155A Method for production of dicarboxylic acids |
| 03/01/2000 | CN1246154A OB fusion protein compositions and methods |
| 03/01/2000 | CN1246153A Mutant alpha-amylase comprising modification at residues corresponding to A210, H405 and/or T412 in Bacillus Licheniforms |
| 03/01/2000 | CN1246152A Esterases, DNA encoding therefor and vectors and host cells incorporating same |
| 03/01/2000 | CN1246151A Mutants of streptococcal toxin A and methods of use |
| 03/01/2000 | CN1246150A Generation of diversity in combinatorial libraries |
| 03/01/2000 | CN1246149A Thermostable endo-beta-1,4-glucanase |
| 03/01/2000 | CN1246148A Enlarged cellulase compositions for use in treatment of textiles |
| 03/01/2000 | CN1246147A Enzymatic process for preparation of cephalosporanic 7 beta-(4-carboxybutanamide) acid by means of modified enzyme D-aminoacid oxidase of trigonopsis variabilis produced in escherichia coli |
| 03/01/2000 | CN1246126A Antimicrobially active polypeptides |
| 03/01/2000 | CN1245832A Genome analysis of 7.3 Kb fragment of hypotoxic vaccine strain of chicken pox virus |
| 03/01/2000 | CN1245721A Method for preparing intestinal transmitted non-A and non-B hepatitis vaccine |
| 03/01/2000 | CN1245720A Medicinal composition containing calcineurin B subunit |
| 03/01/2000 | CN1245719A Antithrombosis medicine using inactive insuline as skeleton and containing arginine-glycine-aspartic acid sequence |
| 03/01/2000 | CA2246791A1 Treatment of endothelium with somatostatin analogues |
| 02/29/2000 | US6031156 Heterologous gene expression utilizing plant asparagine synthetase promoters |
| 02/29/2000 | US6031155 Arabinoxylan degradation |
| 02/29/2000 | US6031154 Fructokinase genes and their use in metabolic engineering of fruit sweetness |
| 02/29/2000 | US6031153 Method for protecting plants |
| 02/29/2000 | US6031152 Promoter from a lipid transfer protein gene |
| 02/29/2000 | US6031151 Callus-specific promoters |
| 02/29/2000 | US6031150 Genome with homozygous disruption of gene by selectable marker; for studying non-insulin dependent diabetes mellitus and persistent hyperinsulinemic hypoglycemia of infancy |
| 02/29/2000 | US6031149 Exhibit specific phenotypes; for screening compounds which act as antagonists or agonists |
| 02/29/2000 | US6031092 Preparation of phosphorothioate oligomers |
| 02/29/2000 | US6031090 Molecular cloning of a 7TM receptor (GPR31A) |
| 02/29/2000 | US6031089 For screening assays for modulators of adenosine triphosphate sensitive channel proteins |
| 02/29/2000 | US6031087 Nucleotide sequences or complementary sequences of a type ii serine protease inhibitor precursor from a plant; for pathogen resistant transgenic plants |
| 02/29/2000 | US6031086 Antisense oligonucleitide containing compositions and method of forming duplexes |
| 02/29/2000 | US6031080 Chemotactic cytokine |
| 02/29/2000 | US6031079 Amino acid sequence; for screening modulators |
| 02/29/2000 | US6031077 For prevention and treatment of heartworm infections; parasiticides; anthelmintics |
| 02/29/2000 | US6031076 Conservin compositions |
| 02/29/2000 | US6031071 Oligopeptide of a generic amino acid sequence having a tryptophan or phenylalanine at a specific site; capable of binding molecules or their natural receptor; for agonists or antagonists |
| 02/29/2000 | US6030947 Treating p150,95-mediated inflammation which comprises administering an anti-inflammatory agent comprising alpha-subunit of human p150,95 in association with beta-subunit of member of lfa-1 family of receptor molecules |
| 02/29/2000 | US6030945 Apo-2 ligand |
| 02/29/2000 | US6030837 Antisense inhibition of PEPCK-mitochondrial expression |
| 02/29/2000 | US6030835 Methods and composition for identifying group a streptococcus |
| 02/29/2000 | US6030834 Cdna (complementary dna) of human i kappa b kinase involved in activating transcription factors and causing inflammation; for drug screening of antiinflammatory agents |
| 02/29/2000 | US6030833 Genetically engineered cell which includes one or more of a human human leukocyte antigen a, b, c, or g transgene; for organ transplants with immunosuppression of human natural killer cell mediated attack |
| 02/29/2000 | US6030831 Tie ligand homologues |
| 02/29/2000 | US6030830 Nucleotide sequences which are bridging templates for recombination of genomic dna resulting in immunoglobulin isotype switching; for treatment of allergies |
| 02/29/2000 | US6030825 Cyclophilin-type peptidyl-prolyl cis/trans isomerase |
| 02/29/2000 | US6030822 Amino acid sequence; for treating skeletal muscle diseases, alzheimer's disease, or peripheral neuropathies in a mammal with an agonist or antagonist of kinase activity; antidiabetic agents |
| 02/29/2000 | US6030817 Transferring portion of the genome of xanthomonas campestris into a sphingomonas species enabling efficient xanthan gum production |
| 02/29/2000 | US6030814 Reverse transcription method |
| 02/29/2000 | US6030813 Phosphoramidate-phosphodiester oligonucleotide chimera utilized as primers |
| 02/29/2000 | US6030812 Fusion proteins comprising multiply mutated interleukin-3 (IL-3) polypeptides and second growth factors |
| 02/29/2000 | US6030811 Polynucleotides encoding a human mystrophin clone, HSABH01 |
| 02/29/2000 | US6030810 Nucleotide and amino acid sequence of voltage-gated transport protein; for diagnosis and therapy of nervous system disorders; antiepileptic agents |
| 02/29/2000 | US6030808 Nucleic acids encoding receptor recognition factor stat 3 and methods of use thereof |
| 02/29/2000 | US6030807 Nucleic acid from the bacillus substilis l-arabinose operon for gene expression in prokaryotic hosts; inducible with exogenous l-arabinose and repressible with exogenous glucose |
| 02/29/2000 | US6030804 Nucleotide and amino acid sequences; for prevention and/or treatment of osteoporosis, hypercalcemia, hypoparathyroidism, hypophosphatemia, kidney stones, nephrolithiasis, and chronic tetany |
| 02/29/2000 | US6030801 Amino acid sequence of enzyme; for screening a library for molecules which bind the polypeptide; diagnosis, treatment or prevention of cancer, immune and reproductive disorders; anticarcinogenic agents |
| 02/29/2000 | US6030795 Recombinant TGF-β type I receptor variants having differentially diminished capacity to signal for matrix protein production |
| 02/29/2000 | US6030794 Determining subtype or isoform bound by agent by incubating agent with one or more cell lines homozygous for a disruption in one or more of its receptor genes, determining the amount of agent, and comparing to control cells |
| 02/29/2000 | US6030793 Immunoassay for detecting a cell proliferation disorder using antibodies against proteins with a defined expression in prostate tissue; for diagnosis and monitoring the stage of malignancy |
| 02/29/2000 | US6030792 Quantitative immunoassay using capture and detection antibodies against specific amino acid sequences of collagen fragments resulting from collagenase cleavage of type ii collagen |
| 02/29/2000 | US6030787 Hybridization assay using self-quenching fluorescence probe |
| 02/29/2000 | US6030786 Antisense modulation of RhoC expression |
| 02/29/2000 | US6030785 Incubating a mixture containing pkr protein kinase, a viral protein containing an interferon sensitivity determining region, and an agent to be tested; then measuring the protein kinase activity where activity indicates an antiviral agent |
| 02/29/2000 | US6030784 Method for simultaneous identification of differentially expressed mRNAS and measurement of relative concentrations |
| 02/29/2000 | US6030782 Covalent attachment of nucleic acid molecules onto solid-phases via disulfide bonds |
| 02/29/2000 | US6030780 Screening drugs that modulate ability of signal transducers and activators of transcription protein dimers to interact and bind dna binding sites by measuring affinity of n-terminal domain to weak and strong binding sites |
| 02/29/2000 | US6030779 Screening for novel bioactivities |
| 02/29/2000 | US6030776 Parallel SELEX |
| 02/29/2000 | US6030774 Hybridization assay to detect presence of a polynucleotide analyte with specific sequences |
| 02/29/2000 | US6030772 Neutralizing antibodies against HIV infection |
| 02/29/2000 | US6030771 Mosaic protein and restriction endonuclease assisted ligation method for making the same |
| 02/29/2000 | US6030769 Strains of human immunodeficiency virus; for use as sensitive diagnositic agents and immunogenic compositions |
| 02/29/2000 | US6030626 Method for preparing the fimbrin protein of Haemophilus influenzae |
| 02/29/2000 | US6030624 Mucosal immunogens for novel vaccines |
| 02/29/2000 | US6030617 Use of growth differentiation factor-9 (GDF-9) to inhibit oocyte maturation |
| 02/29/2000 | US6030615 Combination method for treating diseases caused by cytokine-mediated toxicity |
| 02/29/2000 | US6030611 Administering cuzn superoxide dismutase to organ recipient following transplantation |
| 02/29/2000 | US6030602 Peptide conjugates for transfecting cells |
| 02/29/2000 | CA2280049A1 Diarylsulfonylurea binding proteins |
| 02/29/2000 | CA2182207C Paramunity inducer based on combinations of poxvirus components, process to prepare it and its use as medicament |
| 02/29/2000 | CA2093928C Monoclonal antibodies for detection and treatment of cancer |
| 02/29/2000 | CA2077753C Purified gp120 composition retaining natural conformation |
| 02/29/2000 | CA2050072C Liposome for entrapping gene, liposomal preparation and process for the manufacture of the preparation |
| 02/29/2000 | CA2033347C Monoclonal antibodies against leukocyte adhesion receptor beta-chain, methods of producing these antibodies and use therefore |
| 02/29/2000 | CA1340916C Method for enhancing production of secondary metabolites using clustered biosynthetic genes |
| 02/29/2000 | CA1340915C Myeloperoxydase humaine et application therapeutique |
| 02/28/2000 | CA2281442A1 Use of a cationic polymer for the preparation of a complex with nucleic acid and related compositions |
| 02/28/2000 | CA2249037A1 Novel compounds |
| 02/26/2000 | CA2280675A1 Enhanced phosphorylation of p53 by atm in response to dna damage |
| 02/24/2000 | WO2000009758A1 NOVEL AMPLICON IN THE 20q13 REGION OF HUMAN CHROMOSOME 20 AND USES THEREOF |
| 02/24/2000 | WO2000009755A2 Domain specific gene evolution |